Thomas Alfred
Thomas Alfred Inglin, Loveland, OH US
Patent application number | Description | Published |
---|---|---|
20080275113 | Antimicrobial Compositions, Products, And Methods Of Use - The present invention comprises an antimicrobial composition. More particularly to an antimicrobial composition that comprises a. from about 0.01% to about 15% of at least one non-anionic surfactant, by weight of the composition; b. from about 0.01% to about 15% of at least one acid, by weight of the composition; c. from about 0% to about 99.85% of water, by weight of the composition; and wherein the composition is foaming. | 11-06-2008 |
20120152795 | Blister Cards Promoting Intuitive Dosing - A daily blister card housing a unit dose includes a back side and a front side opposite the back side. The front side includes a manufacturer indicator visible on the front side. A face has an outer periphery and a total planar area bounded by the outer periphery. One or more blisters extend outwardly at the face that contain at least three unit doses that are visible from outside the one or more blisters. Each of the one or more blisters includes a shoulder contacting a cavity backing surface and a projected cavity area bounded by the shoulder that is projected onto the cavity backing surface. A total projected cavity area of the one or more blisters is no more than about 45 percent of the total planar area bounded by the outer periphery. | 06-21-2012 |
20120152796 | Blister Cards Promoting Intuitive Dosing - A blister card with a back side and a front side opposite the back side. The front side has a plurality of blisters and each blister contains a unit dose and each unit dose contains an active. Each blister card contains from about 12 hours to about 24 hours of unit doses according to the dosage instructions. The actives can be the same or different. | 06-21-2012 |
20150068930 | Blister Cards Promoting Intuitive Dosing - A blister card with a back side and a front side opposite the back side. The front side has a plurality of blisters and each blister contains a unit dose and each unit dose contains an active. Each blister card contains from about 12 hours to about 24 hours of unit doses according to the dosage instructions. The actives can be the same or different. | 03-12-2015 |
Thomas Alfred Paul, Waedenswil CH
Patent application number | Description | Published |
---|---|---|
20140306718 | Method And Device For Determining An Operating Parameter Of A Fluid Insulated Electrical Apparatus - A method for deriving at least one operating parameter of a fluid-insulated electrical apparatus, in particular of gas-insulated switchgear. The operating parameter is dependent on a dielectric breakdown strength of an insulation fluid of the electrical apparatus. The insulation fluid includes at least three components that are assigned to at least a first and a second component group such that at least one component group comprises at least two components. The component groups differ in their weighted average values of the molecular masses of the components in the respective component groups. At least one quantity which is indicative of the concentration of the first component group and of the concentration of the second component group is determined from the insulation fluid, e.g. by measuring one or more measurement variables with one or more sensors. The operating parameter is then derived using the at least one quantity. | 10-16-2014 |
20140321031 | Method For Operating An Electrical Apparatus - A method and device for operating a fluid-insulated electrical apparatus. The insulation fluid of the electrical apparatus includes at least two components. The method includes the step of determining a physical state of the insulation fluid by measuring at least three measurement variables with sensors. The method further includes the step of deriving trend variables indicative of changes over time for the measurement variables and/or for characterizing variables. These characterizing variables are derived from the measurement variables by using a relating equation, such as an equation of state, and are also indicative of the physical state of the insulation fluid. By testing for specific patterns of the trend variables, an operating state of the electrical apparatus is determined. The possible operating states correspond to specific and distinguishable non-fault and fault scenarios for the electrical apparatus. Thus, operating states can be distinguished and trouble-shooting in case of a failure is simplified. | 10-30-2014 |
20140331766 | Method For Measuring A Fluid Density Or A Fluid Viscosity - A method and device for estimating a density value ρ | 11-13-2014 |
Thomas Alfred Paul, Wadenswil CH
Patent application number | Description | Published |
---|---|---|
20150214701 | Apparatus Containing A Dielectric Insulation Gas Comprising An Organofluorine Compound - An apparatus for the generation, the distribution or the usage of electrical energy, the apparatus including a housing enclosing an insulating space and an electrical component arranged in the insulating space. The insulating space contains a dielectric insulation gas including an organofluorine compound A. The apparatus further includes a molecular sieve arranged such as to come into contact with the insulation gas. The molecular sieve has an average pore size y greater than the molecular size of at least one decomposition product of the organofluorine compound A generated during operation of the apparatus. The adsorption capability of the molecular sieve for organofluorine compound A is lower than for the at least one decomposition product. The apparatus further includes at least one desiccant arranged such as to come into contact with the insulation gas. | 07-30-2015 |
Thomas Alfred Profitlich, Leiderdorp NL
Patent application number | Description | Published |
---|---|---|
20120003309 | Solid Dosage Forms Of Bendamustine - In the present invention there is provided a pharmaceutical composition in a solid dosage form suitable for oral administration, the composition comprising bendamustine or a pharmaceutically acceptable ester, salt or solvate thereof as an active ingredient, and at least one pharmaceutically acceptable excipient, which is a pharmaceutically acceptable saccharide selected from the group consisting of one or more of a monosaccharide, a disaccharide, an oligosaccharide, a cyclic oligosaccharide, a polysaccharide and a saccharide alcohol, wherein the ratio by weight of the active ingredient to the saccharide excipient(s) is in the range of 1:1-5. | 01-05-2012 |
20140004190 | Solid Dosage Forms of Bendamustine | 01-02-2014 |